The No Surprises Act (NSA) has been in effect since January 2022, and has faced litigation ever since from healthcare providers. States and federal agencies are also examining surprise billing and consumer protection laws related to some provisions of the NSA. Here we review the state of NSA litigation, oversight activities, and rulemaking and guidance as we approach Q4 2023, and share our views on what lies ahead for healthcare providers.
For more from McDermott on the NSA, visit our Resource Center.
For more information, contact Brian R. Stimson (McDermott Will & Emery – Partner), Jeffrey Davis, Kristen O’Brien or Emily R. Curran (McDermott Will & Emery – Associate).
